Syndax Pharmaceuticals, Inc. Share Price
NASDAQ: SNDXHealthcare
Live Syndax Pharmaceuticals, Inc. Share Price Chart
O H L
Syndax Pharmaceuticals, Inc. Performance Overview
Days Range
▼
$17.54Low
$17.79High
Markets Today
| Previous Close | $17.68 |
|---|---|
| Open | $17.62 |
| Volume | 355,600 |
| Day's Range | $17.54 - $17.79 |
| 52W Range | $0.00 - $0.00 |
| Market Cap | $1.54 B |
Historical Performance
| 1M Returns | -11.22 |
|---|---|
| 3M Returns | -6.95 |
| 6M Returns | -25.24 |
| 1Y Returns | +14.43 |
| 5Y Returns | -10.71 |
| 10Y Returns | +28.12 |
Syndax Pharmaceuticals, Inc. Fundamentals
| Market Cap | $1.54 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $172.35 M |
| ROE TTM | -1.62 |
| EPS TTM | $0.00 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 102.03 |
| EBITDA | $-273.08 M |
| Profit Margin | -165.60 |
| Market Cap | $1.54 B |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $172.35 M |
| ROE TTM | -1.62 |
| EPS TTM | $0.00 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 102.03 |
| EBITDA | $-273.08 M |
| Profit Margin | -165.60 |
Syndax Pharmaceuticals, Inc. Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $20.04 M | $37.96 M | $45.87 M | $68.73 M | $64.86 M | $72.79 M |
| Gross Profit + | $19.16 M | $36.68 M | $43.77 M | $66.02 M | $62.23 M | $69.58 M |
| Operating Income | -$91.81 M | -$69.35 M | -$65.71 M | -$38.36 M | -$46.05 M | -$39.99 M |
| EBITDA | -$91.56 M | -$69.35 M | -$65.71 M | -$38.36 M | -$46.04 M | -$39.99 M |
| Interest Expense | -$2.00 K | -$7.86 M | $0 | $0 | $0 | -$12.68 M |
| Depreciation | $247.00 K | $0 | $0 | $3.00 K | $4.00 K | $5.00 K |
| Income Before Tax | -$84.85 M | -$71.85 M | -$60.72 M | -$68.01 M | -$42.67 M | -$49.36 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$84.85 M | -$71.85 M | -$60.72 M | -$68.01 M | -$42.67 M | -$49.36 M |
| Net Profit Margin | -423.34% | -189.28% | -132.36% | -98.96% | -65.79% | -67.82% |
Syndax Pharmaceuticals, Inc. Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $9.00 K | $9.00 K | $9.00 K | $9.00 K | $9.00 K | $9.00 K |
| Reserve & Surplus | -$1.31 B | -$1.38 B | -$1.44 B | -$1.51 B | -$1.55 B | -$1.60 B |
| Non-Current Liabilities | $331.10 M | $325.74 M | $322.18 M | $344.96 M | $344.87 M | $588.88 M |
| Current Liabilities | $94.55 M | $112.99 M | $114.19 M | $120.12 M | $86.17 M | $99.68 M |
| Total Liabilities | $425.65 M | $438.73 M | $436.36 M | $465.08 M | $431.05 M | $688.55 M |
| Fixed Assets | $0 | $0 | $128.00 K | $181.00 K | $177.00 K | $212.00 K |
| Current Assets | $548.75 M | $531.68 M | $529.83 M | $528.08 M | $471.18 M | $675.04 M |
| Total Assets | $640.71 M | $596.15 M | $551.79 M | $529.71 M | $472.67 M | $703.65 M |
Syndax Pharmaceuticals, Inc. Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$84.85 M | -$71.85 M | $0 | -$68.01 M | -$42.67 M | -$49.36 M |
| Operating Cash Flow | -$95.16 M | -$87.80 M | $0 | -$69.49 M | -$50.34 M | -$30.27 M |
| Investing Cash Flow | $94.14 M | $41.89 M | $0 | $81.58 M | $38.39 M | -$16.91 M |
| Financing Cash Flow | $930.00 K | $551.00 K | $0 | $5.92 M | $7.92 M | $252.77 M |
| Change in Cash | -$90.00 K | -$45.36 M | $0 | $18.01 M | -$4.04 M | $205.58 M |
Syndax Pharmaceuticals, Inc. Return Calculator
The Syndax Pharmaceuticals, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$8,960
Invested Amount$10,000
Est. Returns$-1,040
About Syndax Pharmaceuticals, Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.
Popular Stocks
FAQs
What is the share price of Syndax Pharmaceuticals, Inc. today?
Syndax Pharmaceuticals, Inc. (SNDX) share price as of September 18, 2026 is $17.74. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Syndax Pharmaceuticals, Inc.?
Yes, Indian Investors can invest in the Syndax Pharmaceuticals, Inc. (SNDX) Share by opening an international trading account with Angel One.
How can I purchase Syndax Pharmaceuticals, Inc. shares in India?
Purchasing Syndax Pharmaceuticals, Inc. (SNDX) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Syndax Pharmaceuticals, Inc. (SNDX) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Syndax Pharmaceuticals, Inc.?
Yes, you can purchase fractional shares of Syndax Pharmaceuticals, Inc. (SNDX) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Syndax Pharmaceuticals, Inc.?
The market capitalization of Syndax Pharmaceuticals, Inc. on September 18, 2026, is $1.54 B.
In which sector Syndax Pharmaceuticals, Inc. belongs?
Syndax Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Syndax Pharmaceuticals, Inc. stocks?
In order to invest in Syndax Pharmaceuticals, Inc. (SNDX) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
